Genomic Wellness & Preventive Care Services Market Forecasts to 2034 – Global Analysis By Service Type (Genetic Risk Assessment Services, Carrier Screening Services, Pharmacogenomics Services, Lifestyle & Wellness Genomic Counseling, Prenatal & Reproductive Genetic Services, Other Service Types), Testing Type, Application, Delivery Model, End User and By Geography
According to Stratistics MRC, the Global Genomic Wellness & Preventive Care Services Market is accounted for $34.2 billion in 2026 and is expected to reach $95.6 billion by 2034 growing at a CAGR of 13.7% during the forecast period. Genomic Wellness & Preventive Care Services use genetic testing and analysis to assess individual health risks, disease predisposition, and wellness traits. These services provide personalized recommendations related to nutrition, fitness, lifestyle, and preventive healthcare interventions. By identifying genetic markers linked to chronic conditions, users can take proactive steps toward risk reduction and early detection. Offered through healthcare providers, wellness clinics, and direct-to-consumer platforms, genomic wellness services support precision medicine approaches. Increasing consumer interest in personalized health insights, preventive care, and advancements in genomic sequencing technologies are driving market growth.
Market Dynamics:
Driver:
Rising demand for personalized health insights
Expanding use of genetic testing fosters individualized risk assessments. Growing awareness of lifestyle?related diseases accelerates reliance on genomic data for proactive health management. Corporate wellness initiatives propel investment in personalized preventive programs. Strong marketing campaigns highlight the benefits of DNA?based insights, boosting visibility in healthcare ecosystems. Rising consumer preference for proactive wellness fosters substitution of generic health checks with personalized genomic services.
Restraint:
Data privacy and ethics concerns
Ambiguity around data ownership constrains willingness to share genetic information. Limited awareness of secure data protocols hampers credibility. Negative publicity around misuse of genomic data degrades confidence in premium pricing. Cultural resistance to genetic testing hampers uptake in conservative healthcare markets. High skepticism around ethical use of sensitive data constrains repeat purchases. Consequently, privacy concerns continue to limit scalability despite strong personalization drivers.
Opportunity:
Expansion in corporate wellness programs
Advances in workplace health initiatives accelerate integration of DNA?based risk assessments. Strategic collaborations between employers and genomic startups propel commercialization. Expanding investment in employee wellness fosters breakthroughs in personalized preventive solutions. Rising corporate preference for proactive health management accelerates uptake of genomic services. Strong marketing campaigns propel awareness of workplace wellness benefits.
Threat:
Regulatory uncertainty on genomics data
Complex approval processes constrain market entry for novel genomic platforms. Regional disparities in data governance hamper global scalability. High compliance costs degrade margins for smaller providers. Ambiguity around permissible data use hampers consumer trust. Negative publicity around regulatory disputes degrades credibility of genomic services. Consequently, regulatory uncertainty continues to constrain innovation and industry growth.
Covid-19 Impact:
The Covid?19 pandemic accelerated demand for preventive health services, fostering adoption of genomic wellness platforms across diverse demographics. Rising awareness of immunity and chronic disease risks propelled reliance on personalized health insights. Lockdowns constrained in?person consultations, boosting short?term demand for digital genomic services. Supply chain disruptions slowed integration of advanced testing kits. Recovery phases fostered renewed investment in AI?driven preventive care innovation, accelerating adoption post?pandemic.
The risk assessment services segment is expected to be the largest during the forecast period
The risk assessment services segment is expected to account for the largest market share during the forecast period due to rising demand for personalized health insights accelerating reliance on DNA?based risk profiling. Expanding consumer preference for proactive health management fosters consistent adoption. Strong healthcare partnerships accelerate visibility of genomic risk services. Expanding investment in AI?driven analytics fosters breakthroughs in predictive accuracy. Strategic collaborations between providers and insurers propel commercialization. Growing awareness of lifestyle disease prevention fosters uptake across demographics.
The corporate wellness providers segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the corporate wellness providers segment is predicted to witness the highest growth rate as rising demand for personalized health insights accelerates adoption of genomic services in workplace wellness programs. Expanding investment in employee health fosters uptake of DNA?based preventive solutions. Strategic partnerships between employers and genomic startups propel commercialization. Growing awareness of productivity benefits fosters reliance on personalized wellness programs. Strong marketing campaigns accelerate visibility of corporate genomic services.
Region with largest share:
During the forecast period, the North America region is expected to hold the largest market share owing to rising demand for personalized health insights boosting adoption across the United States and Canada. Strong healthcare infrastructure fosters visibility of genomic wellness platforms. Established tech companies accelerate commercialization of preventive care solutions. Rising consumer preference for eco?friendly and health?focused services fosters consistent demand. Strategic collaborations between startups and healthcare systems propel innovation. Expanding e?commerce and telehealth platforms accelerate accessibility of genomic services.
Region with highest CAGR:
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR as rising demand for personalized health insights accelerates adoption across China, India, Japan, and Southeast Asia. Rapid urbanization fosters rising healthcare awareness. Government initiatives propel investment in genomic innovation and safety standards. Rising middle?class incomes accelerate willingness to pay for premium preventive care services. Expanding e?commerce platforms foster visibility of novel categories. Strong marketing campaigns accelerate awareness of personalized genomic offerings.
Key players in the market
Some of the key players in Genomic Wellness & Preventive Care Services Market include Illumina, Inc., Thermo Fisher Scientific Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., Becton, Dickinson and Company, Danaher Corporation, Eurofins Scientific SE, BGI Group, Genomic Health, Inc., Natera, Inc., Myriad Genetics, Inc., Color Health, Inc., Sema4 Holdings Corp. and Prenetics Group Limited.
Key Developments:
In December 2025, QIAGEN completed the acquisition of Parse Biosciences, expanding its Sample technologies portfolio into the high-growth field of single-cell analysis. This acquisition strengthens QIAGEN’s capabilities in translational and clinical research workflows, including applications relevant to preventive care and biomarker discovery.
In August 2024, Genomics highlighted its "Genome.de" service and B2B partnerships for direct-to-consumer genetic testing, offering personalized health, wellness, drug tolerance, and ancestry reports. The service provides consumers with interactive reports and personalized tips based on their genetic makeup to enable preventive health habit changes.
Service Types Covered:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
Market Dynamics:
Driver:
Rising demand for personalized health insights
Expanding use of genetic testing fosters individualized risk assessments. Growing awareness of lifestyle?related diseases accelerates reliance on genomic data for proactive health management. Corporate wellness initiatives propel investment in personalized preventive programs. Strong marketing campaigns highlight the benefits of DNA?based insights, boosting visibility in healthcare ecosystems. Rising consumer preference for proactive wellness fosters substitution of generic health checks with personalized genomic services.
Restraint:
Data privacy and ethics concerns
Ambiguity around data ownership constrains willingness to share genetic information. Limited awareness of secure data protocols hampers credibility. Negative publicity around misuse of genomic data degrades confidence in premium pricing. Cultural resistance to genetic testing hampers uptake in conservative healthcare markets. High skepticism around ethical use of sensitive data constrains repeat purchases. Consequently, privacy concerns continue to limit scalability despite strong personalization drivers.
Opportunity:
Expansion in corporate wellness programs
Advances in workplace health initiatives accelerate integration of DNA?based risk assessments. Strategic collaborations between employers and genomic startups propel commercialization. Expanding investment in employee wellness fosters breakthroughs in personalized preventive solutions. Rising corporate preference for proactive health management accelerates uptake of genomic services. Strong marketing campaigns propel awareness of workplace wellness benefits.
Threat:
Regulatory uncertainty on genomics data
Complex approval processes constrain market entry for novel genomic platforms. Regional disparities in data governance hamper global scalability. High compliance costs degrade margins for smaller providers. Ambiguity around permissible data use hampers consumer trust. Negative publicity around regulatory disputes degrades credibility of genomic services. Consequently, regulatory uncertainty continues to constrain innovation and industry growth.
Covid-19 Impact:
The Covid?19 pandemic accelerated demand for preventive health services, fostering adoption of genomic wellness platforms across diverse demographics. Rising awareness of immunity and chronic disease risks propelled reliance on personalized health insights. Lockdowns constrained in?person consultations, boosting short?term demand for digital genomic services. Supply chain disruptions slowed integration of advanced testing kits. Recovery phases fostered renewed investment in AI?driven preventive care innovation, accelerating adoption post?pandemic.
The risk assessment services segment is expected to be the largest during the forecast period
The risk assessment services segment is expected to account for the largest market share during the forecast period due to rising demand for personalized health insights accelerating reliance on DNA?based risk profiling. Expanding consumer preference for proactive health management fosters consistent adoption. Strong healthcare partnerships accelerate visibility of genomic risk services. Expanding investment in AI?driven analytics fosters breakthroughs in predictive accuracy. Strategic collaborations between providers and insurers propel commercialization. Growing awareness of lifestyle disease prevention fosters uptake across demographics.
The corporate wellness providers segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the corporate wellness providers segment is predicted to witness the highest growth rate as rising demand for personalized health insights accelerates adoption of genomic services in workplace wellness programs. Expanding investment in employee health fosters uptake of DNA?based preventive solutions. Strategic partnerships between employers and genomic startups propel commercialization. Growing awareness of productivity benefits fosters reliance on personalized wellness programs. Strong marketing campaigns accelerate visibility of corporate genomic services.
Region with largest share:
During the forecast period, the North America region is expected to hold the largest market share owing to rising demand for personalized health insights boosting adoption across the United States and Canada. Strong healthcare infrastructure fosters visibility of genomic wellness platforms. Established tech companies accelerate commercialization of preventive care solutions. Rising consumer preference for eco?friendly and health?focused services fosters consistent demand. Strategic collaborations between startups and healthcare systems propel innovation. Expanding e?commerce and telehealth platforms accelerate accessibility of genomic services.
Region with highest CAGR:
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR as rising demand for personalized health insights accelerates adoption across China, India, Japan, and Southeast Asia. Rapid urbanization fosters rising healthcare awareness. Government initiatives propel investment in genomic innovation and safety standards. Rising middle?class incomes accelerate willingness to pay for premium preventive care services. Expanding e?commerce platforms foster visibility of novel categories. Strong marketing campaigns accelerate awareness of personalized genomic offerings.
Key players in the market
Some of the key players in Genomic Wellness & Preventive Care Services Market include Illumina, Inc., Thermo Fisher Scientific Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., Becton, Dickinson and Company, Danaher Corporation, Eurofins Scientific SE, BGI Group, Genomic Health, Inc., Natera, Inc., Myriad Genetics, Inc., Color Health, Inc., Sema4 Holdings Corp. and Prenetics Group Limited.
Key Developments:
In December 2025, QIAGEN completed the acquisition of Parse Biosciences, expanding its Sample technologies portfolio into the high-growth field of single-cell analysis. This acquisition strengthens QIAGEN’s capabilities in translational and clinical research workflows, including applications relevant to preventive care and biomarker discovery.
In August 2024, Genomics highlighted its "Genome.de" service and B2B partnerships for direct-to-consumer genetic testing, offering personalized health, wellness, drug tolerance, and ancestry reports. The service provides consumers with interactive reports and personalized tips based on their genetic makeup to enable preventive health habit changes.
Service Types Covered:
- Genetic Risk Assessment Services
- Carrier Screening Services
- Pharmacogenomics Services
- Lifestyle & Wellness Genomic Counseling
- Prenatal & Reproductive Genetic Services
- Other Service Types
- Direct-to-Consumer (DTC) Services
- Clinic-Based Services
- Hospital-Integrated Services
- Employer-Sponsored Wellness Programs
- Online Genomic Platforms
- Other Delivery Models
- Whole Genome Sequencing
- Whole Exome Sequencing
- Targeted Gene Panels
- SNP Genotyping
- Epigenetic Testing
- Other Testing Types
- Chronic Disease Prevention
- Cancer Risk Assessment
- Cardiovascular Health Screening
- Metabolic Disorder Screening
- Personalized Lifestyle Planning
- Other Applications
- Individuals & Consumers
- Diagnostic Laboratories
- Corporate Wellness Providers
- Research Institutions
- Other End Users
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Netherlands
- Belgium
- Sweden
- Switzerland
- Poland
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Vietnam
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Colombia
- Chile
- Peru
- Rest of South America
- Rest of the World (RoW)
- Middle East
- Saudi Arabia
- United Arab Emirates
- Qatar
- Israel
- Rest of Middle East
- Africa
- South Africa
- Egypt
- Morocco
- Rest of Africa
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
1 EXECUTIVE SUMMARY
1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations
2 RESEARCH FRAMEWORK
2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
2.4.1 Data Collection (Primary and Secondary)
2.4.2 Data Modeling and Estimation Techniques
2.4.3 Data Validation and Triangulation
2.4.4 Analytical and Forecasting Approach
3 MARKET DYNAMICS AND TREND ANALYSIS
3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook
4 COMPETITIVE AND STRATEGIC ASSESSMENT
4.1 Porter's Five Forces Analysis
4.1.1 Supplier Bargaining Power
4.1.2 Buyer Bargaining Power
4.1.3 Threat of Substitutes
4.1.4 Threat of New Entrants
4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison
5 GLOBAL GENOMIC WELLNESS & PREVENTIVE CARE SERVICES MARKET, BY SERVICE TYPE
5.1 Genetic Risk Assessment Services
5.2 Carrier Screening Services
5.3 Pharmacogenomics Services
5.4 Lifestyle & Wellness Genomic Counseling
5.5 Prenatal & Reproductive Genetic Services
5.6 Other Service Types
8 GLOBAL GENOMIC WELLNESS & PREVENTIVE CARE SERVICES MARKET, BY DELIVERY MODEL
8.1 Direct-to-Consumer (DTC) Services
8.2 Clinic-Based Services
8.3 Hospital-Integrated Services
8.4 Employer-Sponsored Wellness Programs
8.5 Online Genomic Platforms
8.6 Other Delivery Models
6 GLOBAL GENOMIC WELLNESS & PREVENTIVE CARE SERVICES MARKET, BY TESTING TYPE
6.1 Whole Genome Sequencing
6.2 Whole Exome Sequencing
6.3 Targeted Gene Panels
6.4 SNP Genotyping
6.5 Epigenetic Testing
6.6 Other Testing Types
7 GLOBAL GENOMIC WELLNESS & PREVENTIVE CARE SERVICES MARKET, BY APPLICATION
7.1 Chronic Disease Prevention
7.2 Cancer Risk Assessment
7.3 Cardiovascular Health Screening
7.4 Metabolic Disorder Screening
7.5 Personalized Lifestyle Planning
7.6 Other Applications
9 GLOBAL GENOMIC WELLNESS & PREVENTIVE CARE SERVICES MARKET, BY END USER
9.1 Individuals & Consumers
9.2 Diagnostic Laboratories
9.3 Corporate Wellness Providers
9.4 Research Institutions
9.5 Other End Users
10 GLOBAL GENOMIC WELLNESS & PREVENTIVE CARE SERVICES MARKET, BY GEOGRAPHY
10.1 North America
10.1.1 United States
10.1.2 Canada
10.1.3 Mexico
10.2 Europe
10.2.1 United Kingdom
10.2.2 Germany
10.2.3 France
10.2.4 Italy
10.2.5 Spain
10.2.6 Netherlands
10.2.7 Belgium
10.2.8 Sweden
10.2.9 Switzerland
10.2.11 Poland
10.2.11 Rest of Europe
10.3 Asia Pacific
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 South Korea
10.3.5 Australia
10.3.6 Indonesia
10.3.7 Thailand
10.3.8 Malaysia
10.3.9 Singapore
10.3.11 Vietnam
10.3.11 Rest of Asia Pacific
10.4 South America
10.4.1 Brazil
10.4.2 Argentina
10.4.3 Colombia
10.4.4 Chile
10.4.5 Peru
10.4.6 Rest of South America
10.5 Rest of the World (RoW)
10.5.1 Middle East
10.5.1.1 Saudi Arabia
10.5.1.2 United Arab Emirates
10.5.1.3 Qatar
10.5.1.4 Israel
10.5.1.5 Rest of Middle East
10.5.2 Africa
10.5.2.1 South Africa
10.5.2.2 Egypt
10.5.2.3 Morocco
10.5.2.4 Rest of Africa
11 STRATEGIC MARKET INTELLIGENCE
11.1 Industry Value Network and Supply Chain Assessment
11.2 White-Space and Opportunity Mapping
11.3 Product Evolution and Market Life Cycle Analysis
11.4 Channel, Distributor, and Go-to-Market Assessment
12 INDUSTRY DEVELOPMENTS AND STRATEGIC INITIATIVES
12.1 Mergers and Acquisitions
12.2 Partnerships, Alliances, and Joint Ventures
12.3 New Product Launches and Certifications
12.4 Capacity Expansion and Investments
12.5 Other Strategic Initiatives
13 COMPANY PROFILES
13.1 Illumina, Inc.
13.2 Thermo Fisher Scientific Inc.
13.3 Qiagen N.V.
13.4 F. Hoffmann-La Roche Ltd
13.5 Agilent Technologies, Inc.
13.6 Becton, Dickinson and Company
13.7 Danaher Corporation
13.8 Eurofins Scientific SE
13.9 BGI Group
13.10 Genomic Health, Inc.
13.11 Natera, Inc.
13.12 Myriad Genetics, Inc.
13.13 Color Health, Inc.
13.14 Sema4 Holdings Corp.
13.15 Prenetics Group Limited
1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations
2 RESEARCH FRAMEWORK
2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
2.4.1 Data Collection (Primary and Secondary)
2.4.2 Data Modeling and Estimation Techniques
2.4.3 Data Validation and Triangulation
2.4.4 Analytical and Forecasting Approach
3 MARKET DYNAMICS AND TREND ANALYSIS
3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook
4 COMPETITIVE AND STRATEGIC ASSESSMENT
4.1 Porter's Five Forces Analysis
4.1.1 Supplier Bargaining Power
4.1.2 Buyer Bargaining Power
4.1.3 Threat of Substitutes
4.1.4 Threat of New Entrants
4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison
5 GLOBAL GENOMIC WELLNESS & PREVENTIVE CARE SERVICES MARKET, BY SERVICE TYPE
5.1 Genetic Risk Assessment Services
5.2 Carrier Screening Services
5.3 Pharmacogenomics Services
5.4 Lifestyle & Wellness Genomic Counseling
5.5 Prenatal & Reproductive Genetic Services
5.6 Other Service Types
8 GLOBAL GENOMIC WELLNESS & PREVENTIVE CARE SERVICES MARKET, BY DELIVERY MODEL
8.1 Direct-to-Consumer (DTC) Services
8.2 Clinic-Based Services
8.3 Hospital-Integrated Services
8.4 Employer-Sponsored Wellness Programs
8.5 Online Genomic Platforms
8.6 Other Delivery Models
6 GLOBAL GENOMIC WELLNESS & PREVENTIVE CARE SERVICES MARKET, BY TESTING TYPE
6.1 Whole Genome Sequencing
6.2 Whole Exome Sequencing
6.3 Targeted Gene Panels
6.4 SNP Genotyping
6.5 Epigenetic Testing
6.6 Other Testing Types
7 GLOBAL GENOMIC WELLNESS & PREVENTIVE CARE SERVICES MARKET, BY APPLICATION
7.1 Chronic Disease Prevention
7.2 Cancer Risk Assessment
7.3 Cardiovascular Health Screening
7.4 Metabolic Disorder Screening
7.5 Personalized Lifestyle Planning
7.6 Other Applications
9 GLOBAL GENOMIC WELLNESS & PREVENTIVE CARE SERVICES MARKET, BY END USER
9.1 Individuals & Consumers
9.2 Diagnostic Laboratories
9.3 Corporate Wellness Providers
9.4 Research Institutions
9.5 Other End Users
10 GLOBAL GENOMIC WELLNESS & PREVENTIVE CARE SERVICES MARKET, BY GEOGRAPHY
10.1 North America
10.1.1 United States
10.1.2 Canada
10.1.3 Mexico
10.2 Europe
10.2.1 United Kingdom
10.2.2 Germany
10.2.3 France
10.2.4 Italy
10.2.5 Spain
10.2.6 Netherlands
10.2.7 Belgium
10.2.8 Sweden
10.2.9 Switzerland
10.2.11 Poland
10.2.11 Rest of Europe
10.3 Asia Pacific
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 South Korea
10.3.5 Australia
10.3.6 Indonesia
10.3.7 Thailand
10.3.8 Malaysia
10.3.9 Singapore
10.3.11 Vietnam
10.3.11 Rest of Asia Pacific
10.4 South America
10.4.1 Brazil
10.4.2 Argentina
10.4.3 Colombia
10.4.4 Chile
10.4.5 Peru
10.4.6 Rest of South America
10.5 Rest of the World (RoW)
10.5.1 Middle East
10.5.1.1 Saudi Arabia
10.5.1.2 United Arab Emirates
10.5.1.3 Qatar
10.5.1.4 Israel
10.5.1.5 Rest of Middle East
10.5.2 Africa
10.5.2.1 South Africa
10.5.2.2 Egypt
10.5.2.3 Morocco
10.5.2.4 Rest of Africa
11 STRATEGIC MARKET INTELLIGENCE
11.1 Industry Value Network and Supply Chain Assessment
11.2 White-Space and Opportunity Mapping
11.3 Product Evolution and Market Life Cycle Analysis
11.4 Channel, Distributor, and Go-to-Market Assessment
12 INDUSTRY DEVELOPMENTS AND STRATEGIC INITIATIVES
12.1 Mergers and Acquisitions
12.2 Partnerships, Alliances, and Joint Ventures
12.3 New Product Launches and Certifications
12.4 Capacity Expansion and Investments
12.5 Other Strategic Initiatives
13 COMPANY PROFILES
13.1 Illumina, Inc.
13.2 Thermo Fisher Scientific Inc.
13.3 Qiagen N.V.
13.4 F. Hoffmann-La Roche Ltd
13.5 Agilent Technologies, Inc.
13.6 Becton, Dickinson and Company
13.7 Danaher Corporation
13.8 Eurofins Scientific SE
13.9 BGI Group
13.10 Genomic Health, Inc.
13.11 Natera, Inc.
13.12 Myriad Genetics, Inc.
13.13 Color Health, Inc.
13.14 Sema4 Holdings Corp.
13.15 Prenetics Group Limited
LIST OF TABLES
Table 1 Global Genomic Wellness & Preventive Care Services Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global Genomic Wellness & Preventive Care Services Market, By Service Type (2023–2034) ($MN)
Table 3 Global Genomic Wellness & Preventive Care Services Market, By Genetic Risk Assessment Services (2023–2034) ($MN)
Table 4 Global Genomic Wellness & Preventive Care Services Market, By Carrier Screening Services (2023–2034) ($MN)
Table 5 Global Genomic Wellness & Preventive Care Services Market, By Pharmacogenomics Services (2023–2034) ($MN)
Table 6 Global Genomic Wellness & Preventive Care Services Market, By Lifestyle & Wellness Genomic Counseling (2023–2034) ($MN)
Table 7 Global Genomic Wellness & Preventive Care Services Market, By Prenatal & Reproductive Genetic Services (2023–2034) ($MN)
Table 8 Global Genomic Wellness & Preventive Care Services Market, By Other Service Types (2023–2034) ($MN)
Table 9 Global Genomic Wellness & Preventive Care Services Market, By Testing Type (2023–2034) ($MN)
Table 10 Global Genomic Wellness & Preventive Care Services Market, By Whole Genome Sequencing (2023–2034) ($MN)
Table 11 Global Genomic Wellness & Preventive Care Services Market, By Whole Exome Sequencing (2023–2034) ($MN)
Table 12 Global Genomic Wellness & Preventive Care Services Market, By Targeted Gene Panels (2023–2034) ($MN)
Table 13 Global Genomic Wellness & Preventive Care Services Market, By SNP Genotyping (2023–2034) ($MN)
Table 14 Global Genomic Wellness & Preventive Care Services Market, By Epigenetic Testing (2023–2034) ($MN)
Table 15 Global Genomic Wellness & Preventive Care Services Market, By Other Testing Types (2023–2034) ($MN)
Table 16 Global Genomic Wellness & Preventive Care Services Market, By Application (2023–2034) ($MN)
Table 17 Global Genomic Wellness & Preventive Care Services Market, By Chronic Disease Prevention (2023–2034) ($MN)
Table 18 Global Genomic Wellness & Preventive Care Services Market, By Cancer Risk Assessment (2023–2034) ($MN)
Table 19 Global Genomic Wellness & Preventive Care Services Market, By Cardiovascular Health Screening (2023–2034) ($MN)
Table 20 Global Genomic Wellness & Preventive Care Services Market, By Metabolic Disorder Screening (2023–2034) ($MN)
Table 21 Global Genomic Wellness & Preventive Care Services Market, By Personalized Lifestyle Planning (2023–2034) ($MN)
Table 22 Global Genomic Wellness & Preventive Care Services Market, By Other Applications (2023–2034) ($MN)
Table 23 Global Genomic Wellness & Preventive Care Services Market, By Delivery Model (2023–2034) ($MN)
Table 24 Global Genomic Wellness & Preventive Care Services Market, By Direct-to-Consumer (DTC) Services (2023–2034) ($MN)
Table 25 Global Genomic Wellness & Preventive Care Services Market, By Clinic-Based Services (2023–2034) ($MN)
Table 26 Global Genomic Wellness & Preventive Care Services Market, By Hospital-Integrated Services (2023–2034) ($MN)
Table 27 Global Genomic Wellness & Preventive Care Services Market, By Employer-Sponsored Wellness Programs (2023–2034) ($MN)
Table 28 Global Genomic Wellness & Preventive Care Services Market, By Online Genomic Platforms (2023–2034) ($MN)
Table 29 Global Genomic Wellness & Preventive Care Services Market, By Other Delivery Models (2023–2034) ($MN)
Table 30 Global Genomic Wellness & Preventive Care Services Market, By End User (2023–2034) ($MN)
Table 31 Global Genomic Wellness & Preventive Care Services Market, By Individuals & Consumers (2023–2034) ($MN)
Table 32 Global Genomic Wellness & Preventive Care Services Market, By Diagnostic Laboratories (2023–2034) ($MN)
Table 33 Global Genomic Wellness & Preventive Care Services Market, By Corporate Wellness Providers (2023–2034) ($MN)
Table 34 Global Genomic Wellness & Preventive Care Services Market, By Research Institutions (2023–2034) ($MN)
Table 35 Global Genomic Wellness & Preventive Care Services Market, By Other End Users (2023–2034) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.
Table 1 Global Genomic Wellness & Preventive Care Services Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global Genomic Wellness & Preventive Care Services Market, By Service Type (2023–2034) ($MN)
Table 3 Global Genomic Wellness & Preventive Care Services Market, By Genetic Risk Assessment Services (2023–2034) ($MN)
Table 4 Global Genomic Wellness & Preventive Care Services Market, By Carrier Screening Services (2023–2034) ($MN)
Table 5 Global Genomic Wellness & Preventive Care Services Market, By Pharmacogenomics Services (2023–2034) ($MN)
Table 6 Global Genomic Wellness & Preventive Care Services Market, By Lifestyle & Wellness Genomic Counseling (2023–2034) ($MN)
Table 7 Global Genomic Wellness & Preventive Care Services Market, By Prenatal & Reproductive Genetic Services (2023–2034) ($MN)
Table 8 Global Genomic Wellness & Preventive Care Services Market, By Other Service Types (2023–2034) ($MN)
Table 9 Global Genomic Wellness & Preventive Care Services Market, By Testing Type (2023–2034) ($MN)
Table 10 Global Genomic Wellness & Preventive Care Services Market, By Whole Genome Sequencing (2023–2034) ($MN)
Table 11 Global Genomic Wellness & Preventive Care Services Market, By Whole Exome Sequencing (2023–2034) ($MN)
Table 12 Global Genomic Wellness & Preventive Care Services Market, By Targeted Gene Panels (2023–2034) ($MN)
Table 13 Global Genomic Wellness & Preventive Care Services Market, By SNP Genotyping (2023–2034) ($MN)
Table 14 Global Genomic Wellness & Preventive Care Services Market, By Epigenetic Testing (2023–2034) ($MN)
Table 15 Global Genomic Wellness & Preventive Care Services Market, By Other Testing Types (2023–2034) ($MN)
Table 16 Global Genomic Wellness & Preventive Care Services Market, By Application (2023–2034) ($MN)
Table 17 Global Genomic Wellness & Preventive Care Services Market, By Chronic Disease Prevention (2023–2034) ($MN)
Table 18 Global Genomic Wellness & Preventive Care Services Market, By Cancer Risk Assessment (2023–2034) ($MN)
Table 19 Global Genomic Wellness & Preventive Care Services Market, By Cardiovascular Health Screening (2023–2034) ($MN)
Table 20 Global Genomic Wellness & Preventive Care Services Market, By Metabolic Disorder Screening (2023–2034) ($MN)
Table 21 Global Genomic Wellness & Preventive Care Services Market, By Personalized Lifestyle Planning (2023–2034) ($MN)
Table 22 Global Genomic Wellness & Preventive Care Services Market, By Other Applications (2023–2034) ($MN)
Table 23 Global Genomic Wellness & Preventive Care Services Market, By Delivery Model (2023–2034) ($MN)
Table 24 Global Genomic Wellness & Preventive Care Services Market, By Direct-to-Consumer (DTC) Services (2023–2034) ($MN)
Table 25 Global Genomic Wellness & Preventive Care Services Market, By Clinic-Based Services (2023–2034) ($MN)
Table 26 Global Genomic Wellness & Preventive Care Services Market, By Hospital-Integrated Services (2023–2034) ($MN)
Table 27 Global Genomic Wellness & Preventive Care Services Market, By Employer-Sponsored Wellness Programs (2023–2034) ($MN)
Table 28 Global Genomic Wellness & Preventive Care Services Market, By Online Genomic Platforms (2023–2034) ($MN)
Table 29 Global Genomic Wellness & Preventive Care Services Market, By Other Delivery Models (2023–2034) ($MN)
Table 30 Global Genomic Wellness & Preventive Care Services Market, By End User (2023–2034) ($MN)
Table 31 Global Genomic Wellness & Preventive Care Services Market, By Individuals & Consumers (2023–2034) ($MN)
Table 32 Global Genomic Wellness & Preventive Care Services Market, By Diagnostic Laboratories (2023–2034) ($MN)
Table 33 Global Genomic Wellness & Preventive Care Services Market, By Corporate Wellness Providers (2023–2034) ($MN)
Table 34 Global Genomic Wellness & Preventive Care Services Market, By Research Institutions (2023–2034) ($MN)
Table 35 Global Genomic Wellness & Preventive Care Services Market, By Other End Users (2023–2034) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.
